Galectins and Disease Implications for Targeted Therapeutics

Anatole Klyosov, Peter G. Traber

$512

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Oxford University Press Inc
27 June 2013

Diseases & disorders; Chemistry; Surface chemistry & adsorption

Series: ACS Symposium Series

Symposium 'Galectin Function and Therapeutics', which took place from September 17-19, 2012 in Boston, has had an important mission: to show the participants and the world where we stand with understanding galectins and theirfunctions and the direct applications of galectin management in practical medicine. This is a very complex and challenging issue. As is shown in Chapter 1, there are more than 3900 articles on galectins; on their structure and functions, published in academic literature since the middle of the 1990's. Most of these papers came from academia. As a result, we have a very advanced science on galectins, 15 of which were identified; on their chemical structure, interactions of galectins with their ligands of both carbohydrate and peptide nature, (alleged) mechanisms of their intracellular and intercellular operations, interception of various biochemical processes, their expression and regulatory effects of the expression, etc. Significant amounts of work have been done with experimental animals, including knockout gal(-/-) mice, as well on effects of galectins and their inhibitors on experimental pathologies in mice, rats, dogs, monkeys. In a few instances galectin inhibitors (galectin blockers) are being tested in human clinical trials, or will be tested soon. It all sounds very encouraging. However, a bird's eye view at these vastresearch areas reveals a somewhat troubling, though not an unusual pattern. An observant eye will notice that the galectin-related field of science, which is essentially biomedical science, consists of four largely disconnected areas. They are connected by only one feature--galectins themselves, which is the main object of attention for the researchers.

Edited by: Anatole Klyosov, Peter G. Traber
Imprint: Oxford University Press Inc
Country of Publication: United States
Volume: 1115
Dimensions: Height: 230mm, Width: 158mm, Spine: 27mm
Weight: 776g
ISBN: 9780841228801
ISBN 10: 0841228809
Series: ACS Symposium Series
Pages: 456
Publication Date: 27 June 2013
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

Anatole Klyosov and Peter Traber are associated with Galactin Therapeutics, Inc., in Norcross, Georgia.